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Background. Velo-cardio-facial syndrome (VCFS) is associated with deletions at chromosome 22q11, abnormalities in
brain anatomy and function, and schizophrenia-like psychosis. Thus it is assumed that one or more genes within the
deleted region are crucial to brain development. However, relatively little is known about how genetic variation
at 22q11 aﬀects brain structure and function. One gene on 22q11 is catechol-O-methyltransferase (COMT) : an enzyme
that degrades dopamine and contains a functional polymorphism (Val158Met) aﬀecting enzyme activity. Here, we
investigated the eﬀect of COMT Val158Met polymorphism on brain anatomy and cognition in adults with VCFS.
Method. The COMT Val158Met polymorphism was genotyped for 26 adults with VCFS on whom DNA was available.
We explored its eﬀects on regional brain volumes using hand tracing approaches ; on regional grey- and white-matter
density using computerized voxel-based analyses ; and measures of attention, IQ, memory, executive and visuospatial
function using a comprehensive neuropsychological test battery.
Results. After corrections for multiple comparisons Val-hemizygous subjects, compared with Met-hemizygotes, had
a signiﬁcantly larger volume of frontal lobes. Also, Val-hemizygotes had signiﬁcantly increased grey matter density
in cerebellum, brainstem, and parahippocampal gyrus, and decreased white matter density in the cerebellum.
No signiﬁcant eﬀects of COMT genotype on neurocognitive performance were found.
Conclusions. COMT genotype eﬀects on brain anatomy in VCFS are not limited to frontal regions but also involve other
structures previously implicated in VCFS. This suggests variation in COMT activity is implicated in brain development
in VCFS.
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Introduction
Velo-cardio-facial syndrome (VCFS) is a genetic dis-
order associated with microdeletions at chromosome
22q11 (Shprintzen et al. 1978), typical facial mor-
phology, cardiovascular anomalies, velopharyngeal
insuﬃciencies, mild to borderline learning disabilities,
cognitive deﬁcits and a high prevalence of psychiatric
disorders including ADHD (Papolos et al. 1996) and
schizophrenia-like psychosis (Murphy et al. 1999). This
high prevalence of psychiatric disorders is likely to be
caused by haploinsuﬃciency of one or more genes on
22q11.
One of the candidate genes located at 22q11 is the
gene for catechol-O-methyltransferase (COMT), an
enzyme that degrades dopamine. Particularly in the
prefrontal cortex (PFC) degradation of dopamine is
largely dependent on activity of COMT, whereas in
other brain regions degradation of dopamine is mainly
by monoamino-oxidase (MAO) and the dopamine
transporter (DAT) (Chen et al. 2004). A common mu-
tation in the COMT gene, leading to an amino acid
substitution [Valine (Val) to Methionine (Met)] results
in decreased enzymatic activity with the Met/Met
variant of COMT showing 40% less enzymatic activity
than the Val/Val variant (Lachman et al. 1996; Chen
et al. 2004).
The COMT Val158Met polymorphism has been re-
ported to : (1) aﬀect midbrain tyrosine hydroxylase
levels and dopamine synthesis (Akil et al. 2003) ;
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(2) modulate dopaminergic interactions between the
PFC and the midbrain (Meyer-Lindenberg et al. 2005 ;
Smolka et al. 2005) ; and (3) aﬀect cognitive functions
dependent on PFC, including working memory and
attention (Egan et al. 2001 ; Malhotra et al. 2002 ; Meyer-
Lindenberg et al. 2005). People with VCFS carry only
one copy of the COMT allele on their intact chromo-
some. It has been suggested that dopaminergic
neurotransmission in VCFS is compromised, thereby
increasing susceptibility for psychosis (Dunham et al.
1992). Therefore studying the COMT Val158Met poly-
morphism in VCFSmay increase our understanding of
brain development and predisposition for psychosis in
this population.
An increasing number of studies have investigated
the eﬀects of the COMT Val158Met polymorphism
on cognitive function in people with VCFS. Some
have reported that in VCFS children the low-activity
Met allele is associated with better performance on
prefrontal-dependent cognitive tasks (Bearden et al.
2004 ; Shashi et al. 2006). However Glaser et al. (2006)
reported no diﬀerence on tasks of executive function
betweenMet-hemizygous andVal-hemizygous groups
in a combined children/adult VCFS population. In
addition the COMT Val158Met polymorphism may
aﬀect overall cognitive ability. For example, some
studies have reported that the Met allele is associated
with a decline in verbal IQ (Gothelf et al. 2005), and
poorer performance on a task of language expression
and spatial working memory (Baker et al. 2005) ;
whereas others found the Met allele to be associated
with higher verbal IQ (Shashi et al. 2006). Thus the ef-
fect of COMT Val158Met polymorphism and cognitive
function in people with VCFS is not easily understood,
and the discrepancy in results of the reported studies
may have arisen because of diﬀerences in dopaminer-
gic neurotransmission due to developmental changes
during adolescence, since both children, adolescents,
and young adults were included in the study popu-
lations (Wahlstrom et al. 2007). The only study to date
on COMT Val158Met polymorphism in adults with
VCFS showed that those with the Met allele displayed
more severe excitement symptoms, and worse per-
formance on theory of mind, Trails B, olfactory
identiﬁcation, communication and social functioning
compared with those with the Val allele (Bassett et al.
2007). However, thus far there is no evidence that the
COMT Val158Met polymorphism aﬀects the prevalence
of schizophrenia in adults with VCFS (Bassett et al.
2007 ; Murphy et al. 1999).
The eﬀects of the COMT Val158Met polymorphism
on brain anatomy in people with VCFS have been less
frequently reported, but Gothelf et al. (2005) found the
Met allele was associated with a smaller frontal lobe
volume. Others, however (Kates et al. 2006), did not
ﬁnd an eﬀect of the COMT Val158Met polymorphism
alone, but did observe a gender-moderated eﬀect of
COMT genotype on both frontal lobe anatomy but not
on frontal-lobe-dependent cognitive tasks.
Thus to date there have been relatively few studies
on the eﬀect of COMT Val158Met polymorphism in
people with VCFS, and those which are available
focused on children and adolescents. Hence, it is un-
clear how the COMT Val158Met polymorphism aﬀects
brain anatomy and cognitive function in adults with
VCFS – and especially in adults. It has been suggested
that PFC dopamine levels peak during adolescence
and decline thereafter (Andersen et al. 1997), and that
COMT activity reaches its optimal levels in early
adulthood in the PFC, which might explain the dis-
crepancies in studies on COMT Val158Met polymor-
phism in children, adolescents and young adults with
VCFS (Tunbridge et al. 2006). We previously reported
on brain anatomy and cognitive function in an adult
VCFS population (van Amelsvoort et al. 2004a, b).
We have retrospectively obtained COMT genotype
data from this sample. Here, we explore the relation-
ship between COMT Val158Met polymorphism and (1)
brain morphometry and (2) measures of intelligence,
attention, working memory, visuospatial function and
memory in adults with VCFS. Because COMT is also
expressed in abundance in non-frontal brain regions
(Tunbridge et al. 2006), we tested the hypothesis that
in adults with VCFS, genetic variation in COMT ac-
tivity is associated with anatomical diﬀerences in
frontal brain regions but also in other regions includ-
ing cerebellum, regions which have been implicated in
VCFS in previous studies. We further hypothesized
that, in agreement with Bassett et al. (2007), in adults
with VCFS those who were Val-hemizygous would
perform better on frontal cognitive tests.
Method
Subjects
The study was approved by the local Ethics
Committee and after complete description of the study
to the subjects, written informed consent was obtained
from themselves and/or their carers. All subjects were
screened for medical conditions aﬀecting brain func-
tioning using a semi-structured clinical interview
and routine clinical blood tests. To establish a DSM-IV
(APA, 1994) diagnosis a semi-structured psychiatric
interview was performed [Schedule for Clinical
Assessment in Neuropsychiatry (SCAN); Wing et al.
1990] as described elsewhere (Murphy et al. 1999). We
included 26 subjects with clinical features of VCFS and
an established 22q11 deletion who have participated
in a previously reported study on brain anatomy
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and/or cognitive function in VCFS (Van Amelsvoort
et al. 2004a, b). Twelve subjects had psychosis, ﬁve
val-hemizygotes and seven met-hemizygotes, were
clinically stable and taking antipsychotic medication.
No other psychiatric disorders were present in the
26 subjects with VCFS.
Genetics
Blood samples were collected from 26 participants,
and DNA was extracted. Fluorescence in situ hy-
bridization (FISH) was used to detect a 22q11 deletion
(Oncor Inc., Gaithersburg, MD). The COMT Val158Met
polymorphism was genotyped using the SNaPshot
technique of single base extension (Applied Biosys-
tems, Foster City, CA, USA) according to manu-
facturer’s instructions. The initial PCR reaction was
performed using a Touchdown-PCR-protocol, with
the following primers : forward: 5k-ACTGTGGCT-
ACTCAGCTGTG-3k and reverse : 5k-CCTTTTTCCA-
GGTCTGACAA-3k. The allele at the SNP position
was determined by use of a 30 bp extension primer
(5k-ATCACCCAGCGGATGGTGGATTTCGCTGGC-3k).
All alleles were resolved on an ABI 3100 sequencer
(Applied Biosystems, Foster City, CA, USA).
Magnetic resonance imaging acquisition and
measurements
Magnetic resonance imaging (MRI) of the brain was
performed on a 1.5-T MRI system (Signa; General
Electric Co, Milwaukee, WI, USA) at the Maudsley
Hospital, London, UK. A coronal volumetric spoiled
gradient acquisition in the steady state dataset cover-
ing the whole head was acquired (repetition time,
13.8 ms; echo time, 2.8 ms; 124 sections ; 1.5-mm sec-
tion thickness). This dataset was used to perform
manual tracing of brain volumes, using Measure
software (Barta et al. 1997). Volumetric analysis by
manual tracing was performed for total intracranial
volume, caudate, putamen, hippocampus, amygdala,
frontal, occipito-parietal and temporal lobes, cerebel-
lum and ventricular and peripheral cerebrospinal
ﬂuid (CSF) by means of region of interest boundaries
as previously described (Murphy et al. 1992, 1993a, b ;
Van Amelsvoort et al. 2001, 2004a). The volume of
each region was calculated by multiplying the
summed pixel cross-sectional areas by section thick-
ness. Intra-rater and inter-rater reliabilities (range,
0.90–0.99) were determined by intra-class correlation
computation for all brain regions traced by two
operators and were highly signiﬁcant (F>4.0 and
p<0.002).
In addition, for determination of grey and white
matter densities we carried out voxel based morpho-
metry on a second dataset that we acquired in the
same individuals : a whole brain near axial dual-echo
fast spin-echo (FSE) dataset aligned with the anterior
commissure (AC)–posterior commissure (PC) plane
[relaxation time (TR)=4000 ms, eﬀective echo time
(TE)=20 and 85 ms, 3 mm slice thickness]. This data-
set was used to examine between-group diﬀerences
in grey and white matter volume using a previously
published methodology (Sigmundsson et al. 2001;
McAlonan et al. 2002 ; Van Amelsvoort et al. 2004a).
Voxels representing extracerebral tissue were auto-
matically set to zero (Suckling et al. 1999a) and the
probability of each intracerebral voxel belonging to
grey matter, white matter, CSF, or dura/vasculature
tissue classes was then estimated by a modiﬁed fuzzy
clustering algorithm (Suckling et al. 1999b). On the
basis of prior results, we equated these probabilities to
the proportional volumes of each tissue class in the
often heterogeneous volume of tissue represented by
each voxel (Bullmore et al. 1995). Thus, for example, if
the probability of grey matter class membership was
0.8 for a given voxel, it was assumed that 80% of the
tissue represented by that voxel was grey matter.
Because the voxel size was predetermined (2.2 mm3),
we then estimated the volume in millilitres of grey
matter, white matter and CSF in each voxel. Summing
these voxel tissue class volumes over all intracerebral
voxels yielded global tissue class volumes. To allow
estimation of between-group diﬀerences at each in-
tracerebral voxel (spatial extent statistics), the short
echo (proton-density-weighted) FSE images were co-
registered using an aﬃne transformation (Press et al.
1992 ; Brammer et al. 1997) with a template image in
the coordinate system of standard space as deﬁned by
Talairach & Tournoux (1988). This individually esti-
mated transformation was then applied to each of that
subject’s grey and white tissue probability maps.
Neuropsychological testing
Overall intellectual functioning, memory, visuospatial
and perceptual ability, executive functioning, and at-
tention were measured. Details of the tests employed
have been described elsewhere (Van Amelsvoort et al.
2004b) but the battery was chosen on suitability for
a learning disabled population and addressing
measures of overall IQ, attention, memory, executive
function and visuospatial function. The test battery
included: a short version of the Weschler Adult
Intelligence Scale – Revised (WAIS-R; Wechsler, 1981)
consisting of ﬁve subtests (Vocabulary, Comprehen-
sion, Similarities, Block Design and Object Assembly) ;
the Doors and People Test of Visual and Verbal Recall
and Recognition (Baddeley et al. 1994) ; two subtests
from the Wechsler Memory Scale – Revised (WMS-R;
Wechsler, 1987) : the Logical Memory (immediate and
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delayed recall of two short stories) and Paired As-
sociates (immediate and delayed recall of matched
pairs) subtests ; the Visual Space and Object Perception
Battery (VOSP; Warrington & James, 1991) ; Compu-
terised Tower of London Task (3-D CTL Test) (Shallice,
1982 ;Morris et al. 1988, 1990) ; Computerised Executive
Golf Task (Morris et al. 1988 ; Baker et al. 1996) ; Control-
led Oral Word Association Test (Benton & Hamsher,
1976) ; Weigl test (Goldstein & Scheerer, 1941) ; and the
Continuous Performance Test (Conner, 1995).
Statistics
The study population was divided into two groups
according to COMT genotype: val-hemizygous and
met-hemizygous VCFS subjects. Diﬀerences in age, and
IQ between the two groups were compared using a
t test ; diﬀerences in gender and psychiatric diagnosis
using a x2 test.
Manually traced brain volumes, computerized tissue class
volumes, and cognitive variables
Data were analysed with SPSS 12.0 for Windows (SPSS
Inc., Chicago, IL). COMT eﬀects on total and regional
brain volumes, total tissue class volumes and cognitive
variables were examined using a univariate analysis of
covariance (ANCOVA) using COMT genotype, and
gender as ﬁxed factors and age and total intracranial
volume (in case of MRI data) as covariates. We sub-
sequently employed Bonferroni corrections for mul-
tiple testing using p<0.0045 for the manually traced
volumes, p<0.017 for the tissue class volumes, and
p<0.0011 for the cognitive variables as levels of stat-
istical signiﬁcance (two-tailed).
Analysis of MRI data using computerized voxel-wise
analysis
Between-group diﬀerences in grey and white matter
were localized by ﬁtting an appropriate GLM at each
intracerebral voxel. Inference was via a permutation
distribution of spatial extent statistics with signiﬁ-
cance levels set to control for multiple comparisons
by having less than one estimated false positive
region (cluster) across the image (p<0.001). In brief,
the processing proceeded as follows. Maps of the
standardized GLM model coeﬃcient of interest
(group) at each voxel were thresholded such that only
voxels with probability<0.05 were retained. The sum
of voxelwise statistics for each three-dimensional
suprathreshold cluster was the test statistic, the
sign indicating a relative excess or deﬁcit in local
tissue density. Signiﬁcance testing of the clusters
was performed using a null distribution of this test
statistic similarly obtained after repeatedly randomly
permuting the relevant factor in the GLM and reﬁtting
of the model (Bullmore et al. 1999).
Results
We studied 26 adults with VCFS. Data on age, gender,
psychiatric diagnosis and intellectual function are
presented in Table 1. Age, psychiatric diagnosis, full
scale IQ (FSIQ) and gender did not diﬀer between val-
and met-hemizygous groups. However, the women in
our sample were signiﬁcantly older than the men;
therefore age was introduced as a covariate in our
analyses. Psychiatric diagnosis and FSIQ did not vary
as a function of gender. We were unable to acquire
MRI scans on seven subjects and neuropsychological
data on three subjects. There were no diﬀerences in
age, psychiatric diagnosis, FSIQ or gender between
val- and met-hemizygous subgroups with the MRI or
the cognitive data.
COMT eﬀects on manually traced brain volumes
After accounting for total intracranial volume and age
there was a signiﬁcant COMT eﬀect on volumes of
frontal (F=30.09, p=0.000), and temporal lobes
(F=10.17, p=0.007), cerebellum (F=8.30, p=0.013) ;
and peripheral CSF (CSF excluding ventricles) (F=
10.84, p=0.006) (Fig. 1). There were no gender ef-
fects or COMTrgender interactions. No signiﬁcant
Table 1. Characteristics of 26 adults with velo-cardio-facial
syndrome
Val (n=14) Met (n=12) p
Age (yr¡S.D.) 30.3 (10.6) 37.33 (10.6) 0.10
Gender, M/F 6/8 3/9 0.43
Psychosis 5 7 0.43
FSIQ (¡S.D.) 71.7 (10.6) 72.32 (13.2) 0.90
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Fig. 1.Mean volumes (ml) of frontal lobes inMet hemizygous
and Val hemizygous velo-cardio-facial syndrome people.
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COMT, gender or COMTrgender interactions
were found in the volume of any other brain region
or ventricles (Table 2). After correction for multiple
comparisons (p<0.0045) only frontal lobe volumes
remained signiﬁcantly diﬀerent, with larger volumes
in the val-hemizygous group compared with the met-
hemizygous group.
COMT eﬀects on total tissue class volumes
Having accounted for total intracranial volume and
age, there was no gender eﬀect on total CSF, grey, and
white matter volume. There was a signiﬁcant COMT
eﬀect on total CSF volume (p=0.028, F=6.38). In ad-
dition there was a signiﬁcant COMTrgender interac-
tion on total white matter volume (p=0.015, F=8.31)
and total CSF volume (p=0.003, F=14.86) (Table 2).
After correction for multiple comparisons (p<0.017)
only a COMTrgender interaction on CSF remained
signiﬁcant.
COMT eﬀects on regional grey matter distribution
There was a signiﬁcant diﬀerence between the
VCFS Val-hemizygous and Met-hemizygous group in
grey matter volume at four spatially extensive 3D
voxel clusters. The Met-hemizygous group had a sig-
niﬁcant reduced grey matter volume in left para-
hippocampal gyrus and brainstem, and bilaterally in
cerebellum. There were no signiﬁcant clusters of
excess grey matter in the Met-hemizygous group
(Table 3, Fig. 2).
COMT eﬀects on regional white matter distribution
The Met-hemizygous group had a signiﬁcantly in-
creased white matter volume in cerebellum. There
were no clusters of reduced white matter in the
Met-hemizygous group (Table 3, Fig. 3).
Table 2.Manually traced brain and computerized tissue class volumes in Val-hemizygous subjects and Met-hemizygous subjects
(corrected for intracranial volume)
Brain structure
Group mean (S.D.), ml
p value F dfVal (n=10) Met (n=9)
Total intracranial volume 1270.639 (50.074) 1314.991 (55.782) 0.571 0.337 1, 14
Frontal lobes 499.154 (5.479) 454.957 (6.216) 0.000** 30.09 1, 13
Occipitoparietal lobes 365.178 (11.253) 363.977 (12.766) 0.946 0.005 1, 13
Temporal lobes 136.855 (5.177) 111.586 (5.873) 0.007* 10.17 1, 13
Putamen 6.632 (0.468) 7.140 (0.497) 0.473 0.548 1, 12
Caudate 7.967 (0.422) 7.588 (0.449) 0.552 0.375 1, 12
Peripheral CSF 126.961 (11.793) 184.760 (13.377) 0.006* 10.84 1, 13
Hippocampus 5.339 (0.307) 4.693 (0.344) 0.197 1.888 1, 11
Amygdala 4.467 (0.329) 4.032 (0.368) 0.406 0.746 1, 11
Cerebellum 109.859 (3.621) 95.740 (4.108) 0.013* 8.30 1, 13
Ventricles 0.995 (0.543) 2.623 (0.616) 0.074 3.768 1, 13
Tissue class volumes
Total grey matter 599.90 (81.90) 560 (101.49) 0.31 1.15 1, 11
Total white matter 577.12 (77.65) 576.26 (70.28) 0.38 0.82 1, 11
Total CSF 158.26 (42.42) 216.20 (105.37) 0.028* 6.38 1, 11
CSF, Cerebrospinal ﬂuid.
* p<0.05, ** p<0.01.
Table 3. Regional diﬀerences in grey and white matter volume
Cerebral region n
Talairach
coordinates (mm)
Sidex y z
Grey matter
Met<Val Deﬁcit
Cerebellum 2948 9.3 x65.1 x19.4 R
Cerebellum 116 x34.3 59.3 x16.6 L
Brainstem 10 x11.0 x36.8 x26.0 L
Parahippo-
campal gyrus
208 x21.9 46.5 x4.8 L
White matter
Met>Val Excess
Cerebellum 4776 7.2 x57.8 21.4 R
n, Number of voxels in each cluster.
The cluster-wise probability is p=0.001.
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COMT eﬀects on cognitive variables
Accounting for age, there were signiﬁcant COMT ef-
fects on two subtests of the Continuous Performance
Test : Variability of Standard Error (p=0.031, F=5.64),
and Standard Error Block Change (p=0.023, F=6.42).
Also there was a signiﬁcant COMT eﬀect on total CPT
index score (p=0.019, F=6.85) and on the minimal
amount of moves needed (MAM) in the Tower of
London task (p=0.019, F=6.96) (Table 4).
Signiﬁcant COMTrgender interactions were found
for Standard Error Block Change of the CPT (p=0.011,
F=8.42), Strategy Formation (p=0.009, F=8.76) and
Between Search Errors (p=0.017, F=6.95) on the Golf
Spatial Working Memory task, MAM of the Tower of
London task (p=0.006, F=10.16), Delayed Logical
Memory of Wechsler memory Scale revised (p=0.021,
F=6.78), Object Discrimination subtest of VOSP
(p=0.018, F=6.79). After Bonferroni correction for
multiple comparisons none of the ﬁndings remained
signiﬁcant.
Discussion
We found that in adults with VCFS, the COMT
Val158Met polymorphism is associated with signiﬁcant
diﬀerences in brain anatomy aﬀecting frontal lobe
volume and grey matter density in cerebellum, brain-
stem and parahippocampal gyrus, and white matter
density in cerebellum.
However, our study has limitations. These include
the relatively small sample size with insuﬃcient
power to look for interactions, and the multiple testing
we carried out. Nevertheless, corrections for multiple
comparisons were applied for all anatomical and cog-
nitive variables. Also it is unlikely that diﬀerences in
age, psychiatric comorbidity, and gender can fully ac-
count for our ﬁndings (as these factors did not diﬀer
between Val- and Met-hemizygous groups). In ad-
dition, we controlled for gender and age in the stat-
istical analysis. Also, as noted by others (Chow et al.
1999), the eﬀect size for structural brain abnormalities
in people with VCFS is relatively large. Nevertheless
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Fig. 2. Relative deﬁcits (blue) and excesses (red) in grey matter volume in Met hemizygous compared with Val hemizygous
VCFS people. The maps are oriented with the right side of the brain shown on the left side of each panel. The z coordinate
for each row of axial slices in the standard space of Talairach & Tournoux (1988) is given in millimetres.
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our ﬁndings should be interpreted with caution and
further studies of a longitudinal nature using larger
samples of people with and without VCFS are re-
quired.
Our study is the ﬁrst to demonstrate that the eﬀect
of the COMT Val158Met polymorphism is not limited to
frontal brain regions in people with VCFS. Because of
the paucity of dopamine transporters in the prefrontal
cortex, COMT is responsible for dopamine degra-
dation in this region (Chen et al. 2004). Therefore, ef-
fects of the COMT Val158Met polymorphism on brain
volume have previously been hypothesized to be most
pronounced in frontal cortex, and this has been the
focus of most studies on brain anatomy and COMT
Val158Met polymorphism (Ho et al. 2005). Our results,
using a whole brain anatomy approach, suggest that
COMT Val158Met polymorphismmay aﬀect other brain
regions as well, including cerebellum, a region par-
ticularly compromised in VCFS (Van Amelsvoort et al.
2004a ; Simon et al. 2005 ; Campbell et al. 2006). COMT
mRNA is expressed in several human brain regions
including the frontal, temporal, and parietal lobes, and
cerebellum, amygdala, putamen, thalamus and spinal
cord (Hong et al. 1998). Therefore it is not surprising
that the Val158Met polymorphism aﬀects other brain
regions than the PFC, which supports our ﬁndings.
Also, COMT may be crucial for dopaminergic
degradation in PFC, but more relevant for regulating
norepinephrine (another substrate of COMT) in other
brain regions. Both these neurochemical systems af-
fect brain development and function. Thus COMT
Val158Met eﬀects on brain anatomymay not only reﬂect
diﬀerences in dopamine degradation but also diﬀer-
ences in (nor)epinephrine metabolism (Parini et al.
1988).
The underlying biological mechanism for our ﬁnd-
ing of larger bulk frontal lobe volumes and increased
grey matter densities in Val-hemizygotes is unclear.
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Fig. 3. Relative deﬁcits (blue) and excesses (red) in white matter volume in Met hemizygous compared with Val hemizygous
velo-cardio-facial syndrome people. The maps are oriented with the right side of the brain shown on the left side of each panel.
The z coordinate for each row of axial slices in the standard space of Talairach & Tournoux (1988) is given in millimetres.
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Table 4. Neuropsychological test scores for velo-cardio-facial syndrome Met and Val subgroups
Val Met p value F df
Intellectual functioning
WAIS-R (n=12) (n=11) 1, 18
Vocabulary 4.58¡2.19 4.18¡2.23 0.27 1.27
Comprehension 4.42¡1.44 4.45¡1.51 0.33 1.00
Similarities 5.58¡0.79 4.91¡1.97 0.14 2.36
Block Design 5.75¡3.38 6.00¡2.90 0.58 0.32
Object Assembly 4.83¡2.66 4.64¡3.04 0.41 0.71
VIQ 73.25¡7.59 71.36¡9.80 0.22 1.61
PIQ 73.58¡15.97 77.36¡18.42 0.24 0.63
FSIQ 71.67¡10.55 72.32¡13.21 0.38 0.82
V-P Discrepancy x0.33¡12.57 x6.0¡12.18 0.80 0.06
Memory
Doors and People (n=12) (n=9) 1, 16
People 5.58¡3.32 5.22¡2.73 0.25 1.44
Doors 3.92¡2.02 5.78¡3.77 0.93 0.01
Shapes 5.08¡4.23 6.11¡3.92 0.68 0.18
Names 6.67¡5.23 6.44¡3.84 0.39 0.80
Overall 3.33¡3.55 4.88¡4.02 0.67 0.20
Visual 4.27¡2.49 6.38¡3.54 0.96 0.00
Verbal 5.67¡4.56 6.25¡3.01 0.50 0.47
Recall 4.67¡3.28 5.62¡2.77 0.37 0.86
Recognition 4.64¡3.38 6.13¡4.12 0.81 0.06
Overall Forgetting 10.50¡4.54 11.22¡2.82 0.78 0.08
WMS-R (n=11) (n=9) 1, 15
Logical Memory Immediate 23.09¡11.26 20.89¡13.0 0.19 1.90
Logical Memory Delayed 6.18¡5.83 5.50¡4.84 0.14 2.49
Paired Associates Immediate 12.36¡5.45 13.89¡6.86 0.76 0.09
Paired Associates Delayed 10.0¡5.51 12.00¡5.45 0.97 0.00
Verbal Memory Index 67.82¡16.6 71.13¡12.92 0.48 0.08
Visuospatial/perceptual functioning
VOSP (n=12) (n=11) 1, 18
Incomplete Letters 19.33¡0.65 19.00¡2.10 0.26 1.33
Silhouettes 13.83¡2.79 17.09¡4.91 0.13 2.49
Object Decision 13.67¡3.17 14.82¡4.45 0.79 0.07
Progressive Silhouettes 12.75¡2.60 11.09¡2.59 0.59 0.30
Dot Counting 9.75¡0.45 9.82¡0.41 0.95 0.00
Position Discrimination 16.00¡3.79 17.55¡2.77 0.58 0.34
Number Location 6.58¡3.50 6.09¡3.18 0.53 0.40
Cube Analysis 6.83¡2.86 6.18¡2.52 0.45 0.59
Number of Passes 4.75¡1.29 5.55¡1.75 0.62 0.25
Spatial Working Memory
Executive Golf Task (n=12) (n=11) 1, 18
Within Search Errors 0.60¡0.85 0.91¡0.91 0.38 0.82
Between Search Errors 4.63¡2.16 5.69¡2.64 0.10 3.07
Strategy Formation 12.35¡1.16 12.55¡1.12 0.32 1.06
Planning and Problem-Solving
Tower of London (n=12) (n=9) 1, 16
Moves Above Minimum 2.74¡1.04 2.02¡1.35 0.03* 5.89
Planning (s) 4.09¡1.94 4.56¡2.41 0.24 1.51
Verbal ﬂuency (n=12) (n=7) 1, 14
Total 22.17¡9.52 23.43¡15.70 0.25 1.47
Weigl (n=12) (n=10) x2
Sorting 100% 90% 0.45 1.59
Shifting 33.3% 60% 0.53 1.28
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One possible explanation could be diﬀerences in brain
maturation between the two genotype groups.
Qualitative imaging studies have reported brain
anomalies in children and adults with VCFS, for ex-
ample agenesis of the corpus callosum, white matter
hyperintensities and septum pellucidum abnormali-
ties (Mitnick et al. 1994 ; Chow et al. 1999 ; Van
Amelsvoort et al. 2001). Quantitative imaging studies
have also reported evidence for disturbed brain
maturation in people with VCFS. For example, several
studies of brain anatomy have reported that people
with VCFS compared with controls often have abnor-
malities in either frontal lobe anatomy (with subtle
diﬀerences in grey/white matter composition) and/or
posterior brain regions including cerebellum (Van
Amelsvoort et al. 2004a ; Simon et al. 2005 ; Campbell
et al. 2006). Normal brain maturation starts from pos-
terior/inferior brain regions and takes place last in
frontal regions (Sowell et al. 1999) and is associated
with an increase in frontal white matter and a decrease
in grey matter during adolescence (Nagy et al. 2004).
Abnormalities in brain maturation (e.g. programmed
cell death) could therefore lead to diﬀerences in the
relative proportions of grey and white matter and
hence frontal lobe volume. Since normal brain matu-
ration is accompanied by increasingly eﬃcient cogni-
tive processing (Levy & Goldman-Rakic, 2000), the
ﬁnding of decreased eﬃciency of prefrontal cognitive
processing in those possessing theVal allele (Egan et al.
2001) perhaps suggests that possessing the Val allele
may slow down the maturation process – and hence
the relative proportion of grey and white matter and/
or bulk volume of frontal regions. A so-called anterior-
posterior dichotomy in anatomical diﬀerences between
people with VCFS and controls has been suggested
(Kates et al. 2001 ; Van Amelsvoort et al. 2004a ; Simon
et al. 2005), and could also explain diﬀerences in brain
anatomy within the VCFS population between those
hemizygous for Val or Met. How COMT haploinsuﬃ-
ciency in VCFS aﬀects the dopaminergic system is still
unknown, although a preliminary open study by Graf
et al. (2001) suggested increased baseline brain dop-
amine levels in three of four patients with VCFS and
the Met-allele, as measured by the level of a catecho-
lamine metabolite, homovanillic acid, in cerebrospinal
ﬂuid compared with calibrated standards and labora-
tory controls. These preliminary ﬁndings suggest that
haploinsuﬃciency in COMT is associated with dys-
regulation of dopaminergic systems. Results from an-
imal and human studies suggest that dopamine has a
trophic action during early brain maturation and later
inﬂuences prefrontal cortical speciﬁcation (Nieoullon,
2002). Therefore, diﬀerences in dopaminergic clear-
ance as a result of Val- or Met-hemizygosity could
result in diﬀerences in (frontal) brain maturation be-
cause of diﬀerences in dopamine signalling during
early brain development. Our ﬁnding of relative cer-
ebellar grey matter increase and white matter decrease
in the Val-hemizygotes suggests that dynamic inter-
play between grey and white matter tissue compo-
sition might take place during brain maturation with
grey matter volume decrease due to pruning and
white matter volume increase during myelination.
These ﬁndings further support the hypothesis that
brain maturation may be slower in val-hemizygotes
than in met-hemizygotes.
Our ﬁndings on cognitive performance did not
survive Bonferroni corrections for multiple compar-
isons. This is probably partially due to our small
sample size. The current literature suggests that cog-
nitive tasks classically thought to be measures of
‘frontal ’ regions are modulated by the COMT poly-
morphism. As mentioned before the results on COMT
polymorphism and cognitive function in VCFS are
Table 4 (cont.)
Val Met p value F df
Attention
CPT (T scores) (n=12) (n=9) 1, 16
Ommission Errors (percentiles) 96.85¡4.44 95.74¡6.36 0.71 0.14
Hit Reaction Times (T scores) 40.70¡7.32 43.97¡8.39 0.19 1.91
Variablility of S.E.’s (T scores) 69.11¡14.78 75.02¡11.99 0.02* 6.20
Hit S.E. Block Change (T scores) 59.76¡14.66 45.41¡22.95 0.02* 7.11
Commission Errors (T scores) 62.05¡13.21 61.23¡14.14 0.67 0.19
Perceptual Sensitivity (T scores) 71.28¡11.32 69.58¡11.01 0.59 0.31
Risk Taking (T scores) 83.28¡15.30 82.22¡18.41 0.46 0.58
CPT Index Score 10.50¡4.19 12.50¡3.99 0.04* 5.28
Values are group means¡S.D.
* p<0.05.
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inconsistent also because various study groups have
used diﬀerent cognitive measures and study popu-
lations included people of diﬀerent ages. Future stud-
ies with larger sample sizes and of a longitudinal
nature should clarify the role of the COMT poly-
morphism on speciﬁc cognitive tasks during lifespan
in VCFS.
In conclusion, our results suggest that genetic vari-
ation in COMT activity aﬀects brain anatomy in adults
with VCFS, and this extends outside frontal brain re-
gions. This suggests variation in COMT activity is im-
plicated in brain development in VCFS. Future studies
are required to investigate changes across the lifespan.
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